This page contains a Flash digital edition of a book.
Technology and product reviews cm2 /cm3


4,5 4


3,5 3


2,5 2


1,5 1


0,5 0


0 14 Figure 17: Mean (+SEM) change in wound size and volume over time.


negative, wound pain and exudate were reduced and healing was evident. While antimicrobial activity is generally


not the primary objective of clinical observations/consultations (this is reserved instead for research studies), experience in over 20 cases has so far revealed that Flaminal can have a positive effect on infected ulcers.


References 17 Van Den Plas D, De Smet K,


Sollie P. Improved Antimicrobial Peroxidase Compositions. 2006; Available at: http://www.wipo. int/patentscope/search/en/


WO2006133523 (accessed 2 March, 2012).


18 Bishop SM, Walker M, Rogers AA, Chen WY. Importance of


moisture balance at the wound- dressing interface. J Wound Care 2003; 12(4): 125–28.


Italian experience This was a single-centre, open-label case series investigating the efficacy of Flaminal in 23 patients with acute and chronic wounds of diverse aetiology (Table 2). Flaminal was applied in accordance with the manufacturer’s instructions and wounds were covered with secondary dressings. A scheduled treatment protocol was applied and patients were assessed at 14, 30 and 60 days. As shown in [Fig 17], this treatment facilitated a clear reduction in wound size and volume over time. It is also noteworthy that in four of the


pressure ulcer cases, healing was evident after just six days of treatment. Further analysis of healing progression is shown in [Fig 18], which illustrates a quantitative overview of the presence of epithelium, granulation, fibrin and necrosis for each wound type prior to treatment (week 0) and after two, four and eight weeks. The wounds began responding within two


weeks of treatment, with higher proportions of fibrin, granulation and epithelium


48 Wounds International Vol 3 | Issue 2 | ©Wounds International 2012


visible, as well as a lack of necrosis. [Fig 19] summarises how pain levels (visual analogue scale [VAS] evaluation) fluctuated before, during and after dressing change at the associated time points, suggesting a trend for a dampening of patient perceived pain over time — this effect may have contributed to the improved healing seen over time [Fig 17], or could have resulted from the healing and reduction in size. These quantifiable outcomes are


supplemented by feedback from the care givers: ‘Flaminal is very easy to use and provides the option to incorporate a second dressing of choice [the study incorporated non-adherent dressings and gauze but foams were most often used] — its presence beneath other dressings has not presented any issues. It demonstrates very good efficacy in


wounds with predominant Gram-positive organisms and compliance with Flaminal schedules has also been noted after one year in some cases’[4]


.


Classification and reimbursement — a French perspective The French perspective focused on the current reimbursement structure in France. Two classes of hydrogels are recognised at present — physical and chemical — and Flaminal falls into the later. Alginates are also a recognised category in the reimbursement of dressings in France — they vary according to carbohydrate


30 60


Surface Volume


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57